![Tacey Viegas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tacey Viegas
Corporate Officer/Principal bei BIOCRYST PHARMACEUTICALS, INC.
Vermögen: 551 520 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Tacey Viegas
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 24 | |
Serina Therapeutics, Inc.
![]() Serina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Tacey Viegas
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal President | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Shire ViroPharma, Inc.
![]() Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
UNITED THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
POWERSECURE INTERNATIONAL, INC. | Electrical Products | Investor Relations Contact | |
Endo Health Solutions, Inc.
![]() Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
PORTAGE BIOTECH INC. | Biotechnology | Founder Director/Board Member | |
VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Undergraduate Degree | |
Stanford University | College/University | Undergraduate Degree | |
University of Melbourne
![]() University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree | |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
The University of Alabama | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
North Carolina State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
Biosynexus, Inc.
![]() Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Indian Institute of Science | College/University | Doctorate Degree | |
GLYCOMIMETICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
US Food & Drug Administration
![]() US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Director/Board Member Corporate Officer/Principal | |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Investment Managers | Consultant / Advisor | |
The University of Alabama at Birmingham | College/University | Corporate Officer/Principal | |
Holy Cross Hospital (Maryland) | Corporate Officer/Principal | ||
Triangle Residential Options for Substance Abusers, Inc.
![]() Triangle Residential Options for Substance Abusers, Inc. Medical/Nursing ServicesHealth Services Triangle Residential Options for Substance Abusers, Inc. provides multi-year residential program. It offers treatment, work-based vocational training, education, and continuing care. The company was founded by Kevin McDonald in 1994 and is headquartered in Durham, NC. | Medical/Nursing Services | Director/Board Member | |
Dublin City University | College/University | Undergraduate Degree | |
Cumberland School of Law At Samford University | College/University | Graduate Degree | |
National Center for Health Statistics | General Government | Corporate Officer/Principal | |
The HudsonAlpha Institute for Biotechnology
![]() The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL. | Biotechnology | Founder Director/Board Member Director/Board Member | |
CLEARSIDE BIOMEDICAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Fuqua School of Business | College/University | Corporate Officer/Principal Masters Business Admin | |
Yale School of Medicine | College/University | Graduate Degree | |
Gw School of Medicine & Health Sciences | College/University | Corporate Officer/Principal | |
PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
Royal Melbourne Hospital
![]() Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Hospital/Nursing Management | Corporate Officer/Principal | |
MELINTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
Canaria Therapeutics, Inc.
![]() Canaria Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Canaria Therapeutics, Inc. operates as a biotechnology company. The company was founded in 2018 and is headquartered in Huntsville, AL. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Lipidio Pharmaceuticals, Inc.
![]() Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lipidio Pharmaceuticals, Inc. develops and manufactures medicines. It focuses on developing drugs to treat diseases associated with excess body fat and its lead program, GDD3898, is being investigated for the treatment of nonalcoholic steatohepatitis (NASH) and Prader Willi syndrome (PWS), an orphan disease, and anti-psychotic drug induced weight gain (AIWG). The company was founded by Jay Edward Birnbaum and is headquartered San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Thirona Bio, Inc.
![]() Thirona Bio, Inc. Pharmaceuticals: MajorHealth Technology Thirona Bio, Inc. is an American biopharmaceutical company that focuses on developing drugs for fibrotic diseases. Thirona Bio is based in an undisclosed location. The private company's target indications include scleroderma, keloid scars, and certain cancers where there are no effective therapies. The company's unique approach uses a potent, topically applied drug to inhibit TGF-? "locally," minimizing the potential risk of systemic toxicity. The company was founded by John Gordon Foulkes, Jay Edward Birnbaum, K. George Mooney, and David A. Bullough, with John Gordon Foulkes serving as the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Vereinigte Staaten | 44 |
Australien | 3 |
Indien | 2 |
Deutschland | 2 |
Irland | 2 |
Sektoral
Health Technology | 29 |
Consumer Services | 15 |
Producer Manufacturing | 3 |
Government | 3 |
Health Services | 3 |
Operativ
Director/Board Member | 155 |
Corporate Officer/Principal | 81 |
Independent Dir/Board Member | 47 |
Undergraduate Degree | 29 |
Chief Executive Officer | 24 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Gregory Bailey | 36 |
George Abercrombie | 26 |
Steven Mintz | 25 |
Stephen Aselage | 20 |
Nancy Hutson | 19 |
Alan Levin | 17 |
Steven Galson | 17 |
Theresa Heggie | 16 |
Vin Milano Milano | 14 |
Steven Ledger | 13 |
Randall Moreadith | 13 |
J. Harris | 12 |
A. Sanders | 11 |
Lonnie McMillian | 10 |
Jon Stonehouse | 10 |
- Börse
- Insiders
- Tacey Viegas
- Unternehmensverbindungen